In Vitro & In Vivo Diagnostic Substances Industry - Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	#o	#f	T	TVal	Price	Qty	oc	Own	H
9/15/25 09:00	9/12/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	2	3	P	110	0.6417	171	3	7,007	D
9/8/25 16:59	9/4/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	4	8	M.d	561	0.6441	871		538	D
9/8/25 16:59	9/4/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	4	8	S.d	-561	0.6441	-871		538	D
9/3/25 17:56	9/1/25	IDXX	Idexx Laboratories Inc /De	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	7	14	M.dm	41,484	372.91	111	527	132	D
8/22/25 16:30	8/20/25	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	5	5	P.m	1,172	10.27	114	38	418	D
8/21/25 17:27	8/13/25	LNTH	Lantheus Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	3	S.m	-382,591	56.14	-6,815		7,063	D
8/20/25 14:49	8/18/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	5	5	M.d	416	5.43	77	17	517	D
8/15/25 16:07	8/13/25	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	S	-19	24.77	-1		35	D
7/17/25 16:09	7/15/25	QDEL	Quidelortho Corp		Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	M.d	145	15.74	9	10	102	D
7/1/25 16:59	6/27/25	TKNO	Alpha Teknova, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	S	-41	5.06	-8		12	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person